Liberale L, Badimon L, Montecucco F, Lüscher TF, Libby P, Camici GG. Inflammation, aging, and cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol. 2022;79(8):837–47.
Article PubMed PubMed Central CAS Google Scholar
Chaligne C, Mageau A, Ducrocq G, Ou P, Alexandra JF, Mutuon P, Papo T, Sacre K. Acute myocarditis revealing autoimmune and inflammatory disorders: clinical presentation and outcome. Int J Cardiol. 2022;351:84–8.
Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T, Cambridge G, Mason JC, Rahimi K, McMurray JJV, Verbakel JY. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet. 2022;400(10354):733–43.
Méndez Eirín E, Suárez Ouréns Y, Guerra Vázquez JL. Cardiac manifestations of rheumatic diseases. Med Clin (Barc). 2021;156(12):615–21.
Weber BN, Paik JJ, Aghayev A, Klein AL, Mavrogeni SI, Yu PB, Mukherjee M. Novel imaging approaches to cardiac manifestations of systemic inflammatory diseases: JACC scientific statement. J Am Coll Cardiol. 2023;82(22):2128–51.
Article PubMed PubMed Central Google Scholar
Drosos GC, Vedder D, Houben E, Boekel L, Atzeni F, Badreh S, Boumpas DT, Brodin N, Bruce IN, González-Gay MÁ, Jacobsen S, Kerekes G, Marchiori F, Mukhtyar C, Ramos-Casals M, Sattar N, Schreiber K, Sciascia S, Svenungsson E, Szekanecz Z, Tausche AK, Tyndall A, van Halm V, Voskuyl A, Macfarlane GJ, Ward MM, Nurmohamed MT, Tektonidou MG. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2022;81(6):768–79.
Article PubMed CAS Google Scholar
Weber B, Garshick M, Liao KP, Di Carli M. Sore, hot, and at risk: the emerging specialty of cardio-rheumatology. J Am Heart Assoc. 2023;12(11):e027846.
Article PubMed PubMed Central Google Scholar
Mavrogeni SI, Sfikakis PP, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Dimitroulas T, Kolovou G, Kitas GD. Cardiac tissue characterization and imaging in autoimmune rheumatic diseases. JACC Cardiovasc Imaging. 2017;10(11):1387–96.
Mavrogeni S, Pepe A, Nijveldt R, Ntusi N, Sierra-Galan LM, Bratis K, Wei J, Mukherjee M, Markousis-Mavrogenis G, Gargani L, Sade LE, Ajmone-Marsan N, Seferovic P, Donal E, Nurmohamed M, Cerinic MM, Sfikakis P, Kitas G, Schwitter J, Lima JAC, Dawson D, Dweck M, Haugaa KH, Keenan N, Moon J, Stankovic I, Donal E, Cosyns B. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 2022;23(9):e308–22.
Article PubMed CAS Google Scholar
Alraies MC, AlJaroudi W, Yarmohammadi H, Yingchoncharoen T, Schuster A, Senapati A, Tariq M, Kwon D, Griffin BP, Klein AL. Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis. Am J Cardiol. 2015;115(4):542–7.
Rosmini S, et al. Non-invasive characterization of pleural and pericardial effusions using T1 mapping by magnetic resonance imaging. Eur Hear J - Cardiovasc Imaging. 2022;23(8):1117–26.
Vidalakis E, Kolentinis M, Gawor M, Vasquez M, Nagel E. CMR in pericardial diseases - an update. Curr Cardiovasc Imaging Rep. 2020;13:1–9.
Geske JB, Anavekar NS, Nishimura RA, Oh JK, Gersh BJ. Differentiation of constriction and restriction: complex cardiovascular hemodynamics. J Am Coll Cardiol. 2016;68:2329–47.
Glower DD. Sticking points in magnetic resonance diagnosis of constrictive pericarditis. J Thorac Cardiovasc Surg. 2016;151:1356–7.
Francone M, Dymarkowski S, Kalantzi M, Rademakers FE, Bogaert J. Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy. Eur Radiol. 2006;16:944–51.
Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2013;34(33):2636–48.
Serra P, Santamaria P. Antigen-specific therapeutic approaches for autoimmunity. Nat Biotechnol. 2019;37(3):238–51.
Article PubMed CAS Google Scholar
Mavrogeni SI, Markousis-Mavrogenis G, Aggeli C, Tousoulis D, Kitas GD, Kolovou G, Iliodromitis EK, Sfikakis PP. Arrhythmogenic inflammatory cardiomyopathy in autoimmune rheumatic diseases: a challenge for cardio-rheumatology. Diagnostics (Basel). 2019;9(4):217.
Article PubMed CAS Google Scholar
Rapezzi C, Arbustini E, Caforio AL, et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2013;34(19):1448–58.
Friedrich MG, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53:1475–87.
Article PubMed PubMed Central Google Scholar
Ferreira VM, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72:3158–76.
De Cobelli F, Pieroni M, Esposito A, et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol. 2006;47(8):1649–54.
Markousis-Mavrogenis G, et al. Coronary microvascular disease: the “Meeting Point” of cardiology, rheumatology and endocrinology. Eur J Clin Invest. 2022;52(5):e13737.
Granitz M, et al. Comparison of native myocardial T1 and T2 mapping at 1.5T and 3T in healthy volunteers: reference values and clinical implications. Wien Klin Wochenschr. 2019;131:143–55.
Article PubMed CAS Google Scholar
Masci PG, Francone M, Desmet W, et al. Right ventricular ischemic injury in patients with acute ST-segment elevation myocardial infarction: characterization with cardiovascular magnetic resonance. Circulation. 2010;122(14):1405–12.
Eitel I, Kubusch K, Strohm O, et al. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging. 2011;4(4):354–62.
Symons R, Pontone G, Schwitter J, et al. Long-term incremental prognostic value of cardiovascular magnetic resonance after ST-segment elevation myocardial infarction: a study of the collaborative registry on CMR in STEMI. JACC Cardiovasc Imaging. 2018;11(6):813–25.
Puntmann VO, et al. Native T1 and ECV of noninfarcted myocardium and outcome in patients with coronary artery disease. J Am Coll Cardiol. 2018;71:766–78.
Tornvall P, Gerbaud E, Behaghel A, et al. Myocarditis or “true” infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: a metaanalysis of individual patient data. Atherosclerosis. 2015;241(1):87–91.
Article PubMed CAS Google Scholar
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction. J Am Coll Cardiol. 2018;72(18):2231–64.
Vágó H, Szabó L, Dohy Z, Czimbalmos C, Tóth A, Suhai FI, Bárczi G, Gyarmathy VA, Becker D, Merkely B. Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries. Heart. 2020;106(13):992–1000.
Mileva N, Paolisso P, Gallinoro E, Fabbricatore D, Munhoz D, Bergamaschi L, Belmonte M, Panayotov P, Pizzi C, Barbato E, Penicka M, Andreini D, Vassilev D. Diagnostic and prognostic role of cardiac magnetic resonance in MINOCA: systematic review and meta-analysis. JACC Cardiovasc Imaging. 2023;16(3):376–89.
Comments (0)